Application of prescribed medicine from rubrics of Synthesis Repertory in cases of type 2 diabetes mellitus assessed by HbA1c with adjuvant therapy in age group of 30to 60 years a Randomised single blind placebo controlled study

This study is a prospective randomized single-blind placebo-controlled true experimental study to assess the clinical utility of prescribed medicine from rubrics of Synthesis Repertory in the management of Type 2 Diabetes Mellitus. The assessment will be done using HbA1c levels as an objective parameter along with adjuvant therapy. A total of 40 participants (20 in each group) in the age group of 30–60 years will be selected according to specific inclusion and exclusion criteria from the outpatient department. The duration of assessment will be 9 months, and outcomes will be evaluated based on the reduction in HbA1c levels at baseline and at the end of the treatment period.